Neogen Corp (NEOG) Stock Price & Analysis
Neogen Corp (NEOG) fell 2.19% to USD 9.4 as of July 25, 2026 at 09:08 UTC, according to Nexqual real-time market data.
NEOG last closed at USD 9.61; the session ranged USD 9.39–9.65 on volume of 1,058,641 shares. Market capitalization is $2.05B, with a 52-week range of USD 4.56–11.43 (NMS). Source: Nexqual, July 25, 2026 at 09:08 UTC.
Key Statistics (as of July 25, 2026 at 09:08 UTC)
| Price | USD 9.4 |
|---|---|
| Change | ▼ 2.19% (down) |
| Previous Close | USD 9.61 |
| Open | USD 9.63 |
| Day Range | USD 9.39 – 9.65 |
| 52-Week Range | USD 4.56 – 11.43 |
| Volume | 1,058,641 shares |
| Market Cap | $2.05B |
| Exchange | NMS |
Technical Analysis (NEOG)
Nexqual's technical model rates NEOG "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 09:08 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.52 (neutral) |
| vs SMA50 | Above (USD 9.23) |
| MACD | 0.15 (positive) |
Analyst Ratings (NEOG)
Wall Street analysts rate NEOG "Buy" based on 3 analysts, with a mean price target of USD 12 (range USD 11–13), per Nexqual as of July 25, 2026 at 09:08 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 12 |
| High Target | USD 13 |
| Low Target | USD 11 |
| Buy / Hold / Sell | 2 / 2 / 0 |
Earnings (NEOG)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0.06 |
| Revenue Estimate | $212.35M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-02-28 | USD 0.09 vs est 0.05 ▲ beat |
| 2025-11-30 | USD 0.1 vs est 0.07 ▲ beat |
| 2025-08-31 | USD 0.04 vs est 0.04 ▲ beat |
| 2025-05-31 | USD 0.05 vs est 0.09 ▼ miss |
Source: Nexqual, July 25, 2026 at 09:08 UTC.
Financials & Fundamentals (NEOG)
| Total Revenue | $870.56M |
|---|---|
| Revenue Growth (YoY) | -4.40% |
| Gross Margin | +45.21% |
| Operating Margin | -1.56% |
| Profit Margin | -69.94% |
| ROE | -25.57% |
| Debt / Equity | 37.82 |
| Current Ratio | 3.92 |
| Total Cash | $159.90M |
| Total Debt | $795.10M |
| Free Cash Flow | $19.47M |
Source: Nexqual, July 25, 2026 at 09:08 UTC.
Financial Health Score (NEOG)
Nexqual rates Neogen Corp's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 09:08 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 45%, operating -2% |
| Balance Sheet | Strong — $160M cash vs $795M debt |
| Cash Flow | Mixed — FCF $19M, slim 2.2% margin |
| Efficiency | Critical — ROE -26%, ROA -0.6% |
Ownership (NEOG)
| Insider Ownership | +0.95% |
|---|---|
| Institutional Ownership | +114.23% |
| Shares Outstanding | 217.67M |
| Float | 216.47M |
| Short % of Float | +6.62% |
Source: Nexqual, July 25, 2026 at 09:08 UTC.
Leadership (NEOG)
Neogen Corp is led by Mikhael Nassif, CEO, President & Director, per Nexqual as of July 25, 2026 at 09:08 UTC.
| CEO, President & Director | Mikhael Nassif |
|---|---|
| CFO & Senior Vice President | R. Bryan Riggsbee (age 55) |
| Chief Scientific Officer | Jeremy Yarwood |
Major Backers & Investors (NEOG)
Notable institutional backers of Neogen Corp include Neuberger Berman Group, LLC, T. Rowe Price, ING Groep N.V., according to Nexqual as of July 25, 2026 at 09:08 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Neuberger Berman Group, LLC | 7.14% |
| T. Rowe Price | 5.9% |
| ING Groep N.V. | 4.09% |
| Mackenzie Financial Corporation | 3.58% |
| Hudson Bay Capital Management Lp | 2.99% |
| BARON INVESTMENT Fd.S TRT -Baron Small Cap Fd. | 2.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 23.44% |
| Vanguard Group | 18.34% |
| Dimensional Fund Advisors | 4.2% |
| State Street | 3.95% |
Source: Nexqual, July 25, 2026 at 09:08 UTC.
From Neogen Corp's Latest SEC 10-K Filing (filed 2025-07-30)
Key Strengths & Strategy (as disclosed to the SEC)
- Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally.
- It operates through two segments, Food Safety and Animal Safety.
- The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and unintended substances in human food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components.
- It also provides software systems that help testers analyze and store results; natural toxin tests; rapid sanitation tests; culture and prepared media products; filter tests for microbial analysis of water; sample collection products; and food safety analysis laboratory services.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MMSI | Merit Medical Systems, Inc. | USD 74.32 | ▲ 1.66% |
| ICUI | ICU Medical, Inc. | USD 157.44 | ▲ 0% |
| EXPO | Exponent, Inc. | USD 61.44 | ▲ 1.19% |
| CNMD | CONMED Corporation | USD 42.68 | ▲ 1.62% |
| OFIX | Orthofix Medical Inc. | USD 11.25 | ▲ 2.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 09:08 UTC. This page is informational and not investment advice.